BCDAW Projected Dividend Yield
Wt Exp 07/26/2022/BioCardia Inc ( NASDAQ : BCDAW )BioCardia is a clinical-stage company focused on developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Co.'s CardiAMP® autologous mononuclear cell therapy platform is being developed for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia. Co.'s neurokinin-1 receptor positive allogeneic mesenchymal stem cell therapy platform is being developed as an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF and for acute respiratory distress syndrome. 20 YEAR PERFORMANCE RESULTS |
BCDAW Dividend History Detail BCDAW Dividend News BCDAW Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |